[When should vaccination of phenprocoumon patients take place?].
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects; D007279:Injections, Subcutaneous / Q000009:adverse effects; D010644:Phenprocoumon / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D014611:Vaccination / Q000009:adverse effects / Q000379:methods
D000925:Anticoagulants; D010644:Phenprocoumon